NIH Calls for BRAIN Proposals

The National Institutes of Health has outlined the types of projects it intends to fund through the federal BRAIN Initiative, and is requesting applications.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NIHBeginning in February, researchers can apply for National Institutes of Health (NIH) funding through President Obama’s BRAIN Initiative, which aims to generate a comprehensive picture of the human brain’s structure and function. This week (December 18), the agency announced requests for applications (RFAs), soliciting projects on technology methods development, among five other “high-priority” research areas outlined by a planning committee earlier this year.

“We have an unprecedented opportunity to develop new technologies that will allow us to map the circuits of the brain, measure activity within those circuits, and understand how their interactions maintain health and modulate human behavior,” said NIH Director Francis Collins in a statement.

Speaking at the American Society for Cell Biology meeting held in New Orleans, Louisiana, this week, BRAIN Initiative planning co-chair Cori Bargmann said that one of the most important things to come from these funds will be “really using technology—not just as a party trick, where you publish a flashy paper and no one ever uses it again.” Optogenetics, pharmacogenomics, and biochemical modulation may all be important tools that NIH seeks to fund, added Bargmann, a neurobiologist at Rockefeller University.

Among ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies